Tags Biotechnology

AI in drug discovery: ADMET property prediction

Discover how artificial intelligence can help you select lead compounds that are both to be effective and do not have adverse effects on patients

Advancing Drug Discovery with Artificial Intelligence

Discover how to enhance your drug discovery pipeline using our novel Artificial Intelligence technology

Fri 29 Apr 2022

ADMET prediction with Artificial Intelligence : Publication

Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"

Mon 14 Mar 2022

Artificial Intelligence for Targeted Protein Degradation

Discover how Kantify’s AI -based drug discovery tool, Zeptomics, accelerates the discovery of promising Targeted Protein Degraders (PROTAC, DUBTAC, LYTAC,...),

Thu 27 May 2021

Key AI Techniques in small molecule screening

Discover the key Artificial Intelligence techniques used for small molecule screening

Fri 19 Mar 2021

ZeptoNet White Paper: AI for drug discovery

We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale

Mon 02 May 2022

Register to our webinar : Targeted Protein Degraders and AI

Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.

Sat 30 Apr 2022

Webinar replay : AI for in silico drug discovery

Watch the replay of our webinar on Zeptomics, Kantify solution for in silico drug discovery

Wed 27 Apr 2022

New discovery with I-Stem (Press Release)

Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease

Wed 13 Apr 2022

Abstract selected for Knowledge For Growth

The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores

Mon 28 Mar 2022

Kantify at the annual event of Brussels' Healthtech cluster

Kantify is speaking at the annual event of the Brussels cluster of healthtech companies

Tue 22 Mar 2022

Unveiling Zeptomics, Kantify’s AI drug discovery technology

Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery

Thu 30 Sep 2021

European Biotech Week: webinar on AI for Drug Discovery

Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021

Wed 01 Sep 2021

Kantify at the European Biotech Week: AI for Drug Discovery

Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development

Tue 24 Aug 2021

Kantify announces new upgrades on ZeptoNet

Kantify announces new upgrades on ZeptoNet - its AI technology for drug discovery

Thu 22 Jul 2021

Kantify joins the European Biotechnology Network

Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences

Mon 10 May 2021

Kantify joins Data-driven Advanced Therapeutics Accelerator

Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst

Wed 14 Apr 2021

The CEO of Kantify interviews with DataNews

The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry

Wed 24 Mar 2021

European Commission Report on AI Uptake in Healthcare

The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.

Fri 19 Mar 2021

Kantify announces its new drug discovery technology

Kantify announces ZeptoNet, its new Virtual screening technology of small molecules

Tue 16 Mar 2021

Kantify at the Belgian AI Week 2021

Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.